1. VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma
   Zhen-Chuan Liu et al, 2017, Oncotarget CrossRef
2. Tamoxifen Modulates the Immune Landscape of the Tumour Microenvironment: The Paired Siglec-5/14 Checkpoint in Anti-Tumour Immunity in an In Vitro Model of Breast Cancer
   Przemyslaw Wielgat et al, 2023, International Journal of Molecular Sciences CrossRef
3. A preliminary analysis of prognostic genes in advanced laryngeal squamous cell carcinoma patients with postoperative radiotherapy
   Chunyan Hu et al, 2023, Pathology - Research and Practice CrossRef
4. REPA: Applying Pathway Analysis to Genome-Wide Transcription Factor Binding Data
   Pranjal Patra et al, 2018, IEEE/ACM Transactions on Computational Biology and Bioinformatics CrossRef
5. Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods
   Ghada Omar Tuffaha et al, 2019, Journal of Molecular Graphics and Modelling CrossRef
6. Induction of c-Jun Expression by Breast Cancer Anti-estrogen Resistance-3 (BCAR3) in Human Breast MCF-12A Cells
   Myung-Ju Oh et al, 2016, Journal of Life Science CrossRef